4-methylumbelliferone attenuates amyloid pathology and learning deficits in the APP/PS1 mouse model
Matthew Amontree, James O’Leary, Pauline M Wonnenberg, Matthew Nelson, Katherine E. Conant
This study shows that 4-MU treatment reduces amyloid pathology and improves memory in APP/PS1 mice.
Scientific Reports · Oct 29, 2026Peer-reviewedNeuroscience